Treatment of Cannabinoid Hyperemesis Syndrome
The definitive treatment for cannabinoid hyperemesis syndrome (CHS) is complete cessation of cannabis use, which is the only intervention that leads to long-term resolution of symptoms. 1
Acute Management
- Topical capsaicin (0.1%) applied to the abdomen is an effective first-line treatment that provides symptom relief by activating transient receptor potential vanilloid type 1 receptors 2, 1
- Antipsychotics are effective for acute symptom management:
- Benzodiazepines can provide relief in the acute setting 2, 3
- Ondansetron may be tried but often has limited efficacy compared to its use in other conditions 1, 4
- Hot showers or baths (hydrothermotherapy) provide temporary symptomatic relief and can be a diagnostic clue 1, 5
- Avoid opioids as they may worsen nausea and carry addiction risk 2, 1
Emergency Department Approach
- Rule out life-threatening conditions first (acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, myocardial infarction) 2, 6
- Consider CHS in patients with:
- Provide supportive care with:
Long-term Management
- Cannabis cessation counseling is essential as the only definitive treatment 1, 5
- Tricyclic antidepressants (particularly amitriptyline) are the mainstay of long-term therapy:
- Psychological support may be beneficial as anxiety and depression are common comorbidities 1, 6
- Consider co-management with psychiatry for patients with extensive psychiatric comorbidity or treatment resistance 1, 6
Diagnostic Criteria for CHS
CHS should be diagnosed based on:
- Clinical features: stereotypical episodic vomiting (≥3 episodes annually) 2, 1
- Cannabis use patterns: >1 year of use before symptom onset, frequency >4 times weekly 2, 1
- Cannabis cessation: resolution of symptoms after abstinence for at least 6 months or duration equal to 3 typical vomiting cycles 2, 1
Common Pitfalls and Caveats
- CHS is often underdiagnosed or misdiagnosed due to limited awareness among clinicians 6
- Patients may report that cannabis helps relieve their symptoms, leading to continued use and worsening of the underlying condition 6
- Many patients remain uncertain about the role of cannabis in their symptoms and may attribute them to other factors like food, alcohol, or stress 6
- Conventional antiemetics including antihistamines and serotonin antagonists may have limited effectiveness 3, 8
- The prevalence of CHS is increasing with the rise in cannabis legalization and higher THC concentrations in modern cannabis products 6, 7
Treatment Algorithm
Acute phase (in ED or acute care setting):
Maintenance phase: